FMP
Sep 14, 2021 6:20 PM - Davit Kirakosyan
aTyr Pharma, Inc. (NASDAQ:LIFE) shares were trading at the highest level since 2018, hitting the daily high of $12.97 today morning.
The reason is that the company presented top-line data from its Phase 1b/2a double-blind, placebo-controlled clinical trial of ATYR1923 in 37 patients with pulmonary sarcoidosis. The data surpassed the expectations, demonstrating a dose dependent improvement in such diverse efficacy measurements as steroid sparing (reduction), Forced Vital Capacity (FVC), clinical/QOL measurements like dyspnea, cough, etc., and inflammatory biomarker reductions; all this with little change in the safety profile of the drug.
Sep 11, 2023 1:38 PM - Rajnish Katharotiya
Price to Earnings is one of the key metrics use to value companies using multiples. The P/E ratio and other multiples are relative valuation metrics and they cannot be looked at in isolation. One of the problems with the P/E metric is the fact that if we are in the peak of a business cycle, earni...
Sep 11, 2023 1:49 PM - Rajnish Katharotiya
Price-to-Earnings ratio is a relative valuation tool. It is used by investors to find great companies at low prices. In this post, we will build a Python script to calculate Price Earnings Ratio for comparable companies. Photo by Skitterphoto on Pexels Price Earnings Ratio and Comparable Compa...
Oct 17, 2023 3:09 PM - Davit Kirakosyan
Shares of VMware (NYSE:VMW) witnessed a sharp drop of 12% intra-day today due to rising concerns about China's review of the company's significant sale deal to Broadcom. Consequently, Broadcom's shares also saw a dip of around 4%. Even though there aren’t any apparent problems with the proposed solu...